Effect of Aficamten on Cardiac Structure and Function in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
Sheila M. Hegde, Xiaowen Wang, Ankit Bhatia, Maria Luisa Peña-Peña et autres
1 citationCirculation
Daniel Jacoby
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
311Publications signalées
11912Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Cardiomyopathy and Myosin StudiesCardiovascular Function and Risk FactorsHeart Failure Treatment and ManagementCardiovascular Effects of ExerciseCardiac Structural Anomalies and Repair
Publications récentes
Global Efficacy of Aficamten in Nonobstructive Hypertrophic Cardiomyopathy: Results From ACACIA-HCM
Martin S. Maron, Ahmad Masri, Ankit Bhatia, Maria Luisa Peña-Peña et autres
1 citationCirculation
The Threshold for a Clinically Meaningful Improvement in Cardiopulmonary Exercise Testing Measures for Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Ahmad Munir Masri, Gregory D. Lewis, Roberto Barriales-Villa, Brian L. Claggett et autres
2 citationsJournal of Cardiac Failure
Aficamten Reduces Eligibility for Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy: Long-Term Outcomes from FOREST-HCM
Ahmad Masri, Benjamin Meder, Lubna Choudhury, Pablo García‐Pavía et autres
0 citationsmedRxiv
Biobank-Scale Plasma Proteomics Identifies Novel Biomarkers in Hypertrophic Cardiomyopathy
Jonathan Chan, Christopher Grace, Mohsen Mazidi, Robert Clarke et autres
1 citationCirculation Genomic and Precision Medicine
26-A-11653-ACC AFICAMTEN VERSUS METOPROLOL IN PATIENTS WITH HYPERTENSION AND OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Neal K. Lakdawala, Pablo García Pavía, Lubna Choudhury, Brian Claggett et autres
0 citationsJournal of the American College of Cardiology
26-A-16519-ACC ELECTROCARDIOGRAPHIC CHANGES AND ASSOCIATIONS WITH ECHOCARDIOGRAPHIC CHANGES IN PATIENTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: INSIGHTS FROM THE SEQUOIA-HCM TRIAL
Alberto Foà, Brian Claggett, Martin S. Maron, Ahmad Masri et autres
0 citationsJournal of the American College of Cardiology
Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy: An Integrated Safety Analysis
A Masri, Martin S. Maron, Roberto Barriales-Villa, Robert M. Cooper et autres
0 citationsmedRxiv
Efficacy of aficamten according to geographic location of patients with hypertrophic obstructive cardiomyopathy
Caroline Coats, Theodore Abraham, Roberto Barriales-Villa, Michael Arad et autres
0 citationsESC Heart Failure
Efficacy and Safety of Aficamten in Children and Adolescents With Obstructive Hypertrophic Cardiomyopathy: Study Design and Rationale of CEDAR-HCM
Juan Pablo Kaski, Paul F. Kantor, Stephanie J. Nakano, Iacopo Olivotto et autres
5 citationsCirculation Heart Failure
Effect of Aficamten vs Metoprolol on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy
Michael E. Nassif, Pablo García‐Pavía, Ahmad Masri, Béla Merkely et autres
2 citationsJournal of the American College of Cardiology
Aficamten in Obstructive Hypertrophic Cardiomyopathy
Andrew Wang, Pablo García‐Pavía, Ahmad Masri, Béla Merkely et autres
4 citationsJournal of the American College of Cardiology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.